Cited 0 times in
Multicenter phase Ib/II study of second-line trastuzumab, ramucirumab, and paclitaxel in patients with HER2-positive advanced gastric or gastroesophageal junction cancer: Updated HER-RAM study with biomarker analysis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김창곤 | - |
dc.contributor.author | 김현기 | - |
dc.contributor.author | 김효송 | - |
dc.contributor.author | 라선영 | - |
dc.contributor.author | 이충근 | - |
dc.contributor.author | 정민규 | - |
dc.contributor.author | 정현철 | - |
dc.contributor.author | 정희철 | - |
dc.date.accessioned | 2023-06-02T01:02:11Z | - |
dc.date.available | 2023-06-02T01:02:11Z | - |
dc.date.issued | 2022-02 | - |
dc.identifier.issn | 0732-183X | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/194609 | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | American Society of Clinical Oncology | - |
dc.relation.isPartOf | JOURNAL OF CLINICAL ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Multicenter phase Ib/II study of second-line trastuzumab, ramucirumab, and paclitaxel in patients with HER2-positive advanced gastric or gastroesophageal junction cancer: Updated HER-RAM study with biomarker analysis | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Sun Young Rha | - |
dc.contributor.googleauthor | Chang Gon Kim | - |
dc.contributor.googleauthor | Minkyu Jung | - |
dc.contributor.googleauthor | Hyo Song Kim | - |
dc.contributor.googleauthor | Choong-kun Lee | - |
dc.contributor.googleauthor | Hei-Cheul Jeung | - |
dc.contributor.googleauthor | Dong-Hoe Koo | - |
dc.contributor.googleauthor | Woo Kyun Bae | - |
dc.contributor.googleauthor | Dae Young Zang | - |
dc.contributor.googleauthor | Hyunki Kim | - |
dc.contributor.googleauthor | Hyun Cheol Cheol Chung | - |
dc.identifier.doi | 10.1200/JCO.2022.40.4_suppl.330 | - |
dc.contributor.localId | A05991 | - |
dc.contributor.localId | A01108 | - |
dc.contributor.localId | A01202 | - |
dc.contributor.localId | A01316 | - |
dc.contributor.localId | A03259 | - |
dc.contributor.localId | A03606 | - |
dc.contributor.localId | A03773 | - |
dc.contributor.localId | A03794 | - |
dc.relation.journalcode | J01331 | - |
dc.identifier.eissn | 1527-7755 | - |
dc.identifier.url | https://ascopubs.org/doi/10.1200/JCO.2022.40.4_suppl.330 | - |
dc.contributor.alternativeName | Kim, Chang Gon | - |
dc.contributor.affiliatedAuthor | 김창곤 | - |
dc.contributor.affiliatedAuthor | 김현기 | - |
dc.contributor.affiliatedAuthor | 김효송 | - |
dc.contributor.affiliatedAuthor | 라선영 | - |
dc.contributor.affiliatedAuthor | 이충근 | - |
dc.contributor.affiliatedAuthor | 정민규 | - |
dc.contributor.affiliatedAuthor | 정현철 | - |
dc.contributor.affiliatedAuthor | 정희철 | - |
dc.citation.volume | 40 | - |
dc.citation.number | 4 suppl | - |
dc.citation.startPage | 330 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CLINICAL ONCOLOGY, Vol.40(4 suppl) : 330, 2022-02 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.